Jim Simons Painreform Ltd. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.43 - $0.69 $1,849 - $2,966	4,300 Added 16.1%	31,000 $17,000
Q1 2023 May 12, 2023	BUY	$0.41 - $0.76 $902 - $1,672	2,200 Added 8.98%	26,700 $18,000
Q4 2022 Feb 13, 2023	SELL	$0.36 - $0.68 $144 - $272	-400 Reduced 1.61%	24,500 $10,000
Q3 2022 Nov 14, 2022	SELL	$0.62 - $0.96 $125 - $193	-202 Reduced 0.8%	24,900 $17,000
Q2 2022 Aug 12, 2022	BUY	$0.72 - $1.31 $2,665 - $4,849	3,702 Added 17.3%	25,102 $24,000
Q1 2022 May 13, 2022	BUY	$0.88 - $1.56 $6,160 - $10,920	7,000 Added 48.61%	21,400 $27,000
Q4 2021 Feb 11, 2022	BUY	$1.26 - $2.83 $18,144 - $40,752	14,400 New	14,400 $19,000

Ticker PRFX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,634,200
Market Cap $6.7M
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-oper...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.